Picomolar Inhibitors of HIV Reverse Transcriptase Featuring Bicyclic Replacement of a Cyanovinylphenyl Group
about
Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitorsPicomolar Inhibitors of HIV-1 Reverse Transcriptase: Design and Crystallography of Naphthyl Phenyl EthersMolecular dynamics and Monte Carlo simulations for protein-ligand binding and inhibitor design.Structure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that target HIV reverse transcriptase variants.Potent Inhibitors Active against HIV Reverse Transcriptase with K101P, a Mutation Conferring Rilpivirine Resistance.Discovery and crystallography of bicyclic arylaminoazines as potent inhibitors of HIV-1 reverse transcriptaseA theoretical view of protein dynamics.Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011-2014).Stereoselective Synthesis of Tetrahydroindolizines through the Catalytic Formation of Pyridinium Ylides from Diazo Compounds.Computer-aided discovery of anti-HIV agents.Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection.Novel fused pyrimidine and isoquinoline derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2016105532A1, WO2016105534A1 and WO2016105564A1.From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection.Design, Conformation, and Crystallography of 2-Naphthyl Phenyl Ethers as Potent Anti-HIV Agents.Formal [3+2] cycloaddition of 1-cyanocyclopropane 1-ester with pyridine, quinoline or isoquinoline: a general and efficient strategy for construction of cyanoindolizine skeletons.
P2860
Q26777448-FEE71AC2-1206-48E8-9360-93E2AD5A70D0Q34519713-B5695ECF-F480-41B5-8F40-2A12463B1C37Q35117666-407F99D8-CFA2-4BBF-BC7F-15B353172684Q35228851-676159EC-121A-4DF0-A9C1-CC87EA8BB8A9Q36146704-16CF30D8-1376-4B7D-A02B-4EAB1674B017Q36167147-086171C9-86D0-48AD-8281-6E261E5E3D66Q38202826-D90718B6-9730-4742-903E-57AC57D1512DQ38260066-6E074AD9-C9F3-469D-93DD-0A1C657DD5FFQ38883772-BCF0D129-1641-4013-864B-B374B3F2675FQ38916780-AB38FC28-441C-4758-8609-96342666B5BBQ38975330-86DA4834-117E-4F29-9E21-E7BF64C3ED17Q39169967-F2AA5CAE-A094-40EE-9695-5ADA1F9AFB97Q47217844-48098622-437A-4E71-84C9-B23DEB1EA3FBQ50317213-7D515C97-19FD-4CA1-B12F-4488380C7C38Q51070413-EEC7042F-0913-490B-952D-E55DEED4DFB9
P2860
Picomolar Inhibitors of HIV Reverse Transcriptase Featuring Bicyclic Replacement of a Cyanovinylphenyl Group
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Picomolar Inhibitors of HIV Re ...... nt of a Cyanovinylphenyl Group
@ast
Picomolar Inhibitors of HIV Re ...... nt of a Cyanovinylphenyl Group
@en
Picomolar Inhibitors of HIV Re ...... nt of a Cyanovinylphenyl Group
@nl
type
label
Picomolar Inhibitors of HIV Re ...... nt of a Cyanovinylphenyl Group
@ast
Picomolar Inhibitors of HIV Re ...... nt of a Cyanovinylphenyl Group
@en
Picomolar Inhibitors of HIV Re ...... nt of a Cyanovinylphenyl Group
@nl
prefLabel
Picomolar Inhibitors of HIV Re ...... nt of a Cyanovinylphenyl Group
@ast
Picomolar Inhibitors of HIV Re ...... nt of a Cyanovinylphenyl Group
@en
Picomolar Inhibitors of HIV Re ...... nt of a Cyanovinylphenyl Group
@nl
P2093
P2860
P356
P1476
Picomolar Inhibitors of HIV Re ...... nt of a Cyanovinylphenyl Group
@en
P2093
Karen S Anderson
Kathleen M Frey
Krasimir A Spasov
Mariela Bollini
Ricardo Gallardo-Macias
Won-Gil Lee
P2860
P304
P356
10.1021/JA408917N
P407
P577
2013-11-06T00:00:00Z